Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 41% ± 24% | |
endothelial cell | 5 studies | 24% ± 6% | |
GABAergic neuron | 5 studies | 43% ± 20% | |
neuron | 4 studies | 29% ± 8% | |
astrocyte | 4 studies | 30% ± 8% | |
interneuron | 4 studies | 41% ± 24% | |
oligodendrocyte | 4 studies | 26% ± 7% | |
oligodendrocyte precursor cell | 3 studies | 28% ± 6% | |
epithelial cell | 3 studies | 19% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 42% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1916.66 | 2641 / 2642 | 100% | 19.18 | 704 / 705 |
esophagus | 100% | 1095.29 | 1445 / 1445 | 99% | 15.15 | 182 / 183 |
prostate | 100% | 986.48 | 245 / 245 | 98% | 13.39 | 491 / 502 |
lung | 99% | 976.21 | 572 / 578 | 99% | 12.64 | 1141 / 1155 |
adrenal gland | 100% | 1293.10 | 258 / 258 | 97% | 22.80 | 224 / 230 |
pancreas | 99% | 818.31 | 326 / 328 | 98% | 9.18 | 174 / 178 |
breast | 100% | 1133.98 | 459 / 459 | 97% | 16.18 | 1080 / 1118 |
thymus | 100% | 1364.82 | 653 / 653 | 96% | 10.62 | 579 / 605 |
stomach | 100% | 1076.52 | 359 / 359 | 95% | 11.39 | 273 / 286 |
intestine | 100% | 1256.55 | 966 / 966 | 94% | 9.40 | 496 / 527 |
kidney | 100% | 685.78 | 89 / 89 | 93% | 11.88 | 834 / 901 |
bladder | 100% | 1283.86 | 21 / 21 | 92% | 8.81 | 465 / 504 |
uterus | 100% | 989.05 | 170 / 170 | 90% | 8.73 | 412 / 459 |
liver | 100% | 972.21 | 226 / 226 | 88% | 8.25 | 358 / 406 |
ovary | 99% | 805.27 | 179 / 180 | 87% | 5.61 | 375 / 430 |
skin | 100% | 1434.39 | 1809 / 1809 | 76% | 6.72 | 361 / 472 |
adipose | 100% | 1113.95 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 923.44 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1367.39 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1321.60 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 864.34 | 821 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 6.99 | 26 / 29 |
tonsil | 0% | 0 | 0 / 0 | 87% | 7.75 | 39 / 45 |
peripheral blood | 59% | 607.74 | 547 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 28% | 1.37 | 22 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071875 | Biological process | adrenergic receptor signaling pathway |
GO_0016020 | Cellular component | membrane |
GO_0005886 | Cellular component | plasma membrane |
Gene name | LMBRD2 |
Protein name | G-protein coupled receptor-associated protein LMBRD2 (LMBR1 domain-containing protein 2) |
Synonyms | |
Description | FUNCTION: Recruited to ligand-activated beta-2 adrenergic receptor/ADRB2, it negatively regulates the adrenergic receptor signaling pathway . May also regulate other G-protein coupled receptors including type-1 angiotensin II receptor/AGTR1 (Probable). . |
Accessions | Q68DH5 ENST00000296603.5 |